share_log
  • Headlines
  • China Galaxy released a research report on April 24 stating that it gave Colon Pharmaceutical (002422.SZ) a recommended rating. The main reasons for the rating include: 1) Infusion continues to exceed expectations, demand is strong & structure is optimize

中国银河4月24日发布研报称，给予科伦药业（002422.SZ）推荐评级。评级理由主要包括：1）输液持续超预期，需求旺盛&结构优化，未来仍将快速增长；2）量价齐升&降本增效，抗生素龙头有望持续快速增长；3）科伦博泰里程碑收入持续兑现，SKB264上市在即备战商业化。（每日经济新闻）

China Galaxy released a research report on April 24 stating that it gave Colon Pharmaceutical (002422.SZ) a recommended rating. The main reasons for the rating include: 1) Infusion continues to exceed expectations, demand is strong & structure is optimize

Zhitong Finance ·  Apr 25, 2024 19:37
China Galaxy released a research report on April 24 stating that it gave Colon Pharmaceutical (002422.SZ) a recommended rating. The main reasons for the rating include: 1) Infusion continues to exceed expectations, demand is strong & structure is optimized, and it will continue to grow rapidly in the future; 2) the antibiotic leader is expected to continue to grow rapidly due to sharp rise in volume and price reduction and efficiency; 3) Collombotai's milestone revenue continues to be realized, and SKB264 is ready for commercialization soon. (Mainichi Keizai Shimbun)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    Beijing Aosaikang Pharmaceutical
    002755
    -- 14.27
    Shandong Wit Dyne Health
    000915
    -- 28.47
    Chongqing Sansheng Industrial
    002742
    -- 3.95
    Hebei Changshan Biochemical Pharmaceutical
    300255
    -- 18.75
    InnoCare Pharma
    688428
    -- 12.26
    Log In for the Full List
    Investment Course
    Choose stocks based on financial reports
    Quickly master financial season learning guidelines
    When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
    How to view Tesla's performance in January 2025? Pay attention to these four key points.
    It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
    In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
    When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha